|
CDC14A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.47419995392085E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.02380001435421E-09 |
| Normal-vs-Stage2 |
1.05259999605423E-08 |
| Normal-vs-Stage3 |
9.3690999403151E-10 |
| Normal-vs-Stage4 |
9.39650002251824E-09 |
| Stage1-vs-Stage2 |
9.567600E-01 |
| Stage1-vs-Stage3 |
1.476570E-01 |
| Stage1-vs-Stage4 |
6.602200E-01 |
| Stage2-vs-Stage3 |
2.741400E-01 |
| Stage2-vs-Stage4 |
6.071400E-01 |
| Stage3-vs-Stage4 |
7.279800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45660003240067E-09 |
| Normal-vs-AfricanAmerican |
5.08649999897415E-09 |
| Normal-vs-Asian |
3.58680000034362E-07 |
| Caucasian-vs-AfricanAmerican |
8.721000E-01 |
| Caucasian-vs-Asian |
7.314800E-01 |
| AfricanAmerican-vs-Asian |
7.294000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03489996969597E-09 |
| Normal-vs-Female |
1.59140000066671E-08 |
| Male-vs-Female |
1.850620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.88419998994982E-09 |
| Normal-vs-Extreme_Weight |
5.03270003449074E-09 |
| Normal-vs-Obese |
7.02839997313021E-09 |
| Normal-vs-Extreme_Obese |
9.4190000243799E-10 |
| Normal_Weight-vs-Extreme_Weight |
6.994400E-01 |
| Normal_Weight-vs-Obese |
5.098400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.085600E-01 |
| Extreme_Weight-vs-Obese |
8.078400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.343560E-01 |
| Obese-vs-Extreme_Obese |
1.594990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47049999954518E-08 |
| Normal-vs-Age(41-60Yrs) |
1.47230000413501E-08 |
| Normal-vs-Age(61-80Yrs) |
3.34990002404112E-09 |
| Normal-vs-Age(81-100Yrs) |
3.84649978535379E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.396200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.568480E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.408390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.742000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.928200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.05790004218443E-09 |
| Normal-VS-Type2 PRCC |
6.51860010414396E-10 |
| Normal-VS-KIRP CIMP |
5.65659999951507E-08 |
| Normal-VS-Unclassified PRCC |
7.5059000015365E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.570040E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.321200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.664230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.007040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.315800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.641000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49709999952563E-09 |
| Normal-vs-N1 |
9.72610003646679E-09 |
| Normal-vs-N2 |
6.695200E-03 |
| N0-vs-N1 |
2.669800E-01 |
| N0-vs-N2 |
8.405400E-01 |
| N1-vs-N2 |
4.833400E-01 |
|
|
